Article
Predictive Biomarker DPY19L1 Reduces Survival in Glioma Patients
2022-05-25
Abstract excerpt
<h4>Background: </h4> Glioblastomas have poor survival outcome. Identifying biomarker for survival differentiation is beneficial for glioma patients. This study aims to investigate the survival outcome and pathological grading of DPY19L1 in human gliomas. <h4>Methods: </h4>: We analyzed the DPY19L1 mRNA expression and survival of human gliomas from the Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CG...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cb9d7218-4d0d-50d9-a979-c2f76ec0b0d1
- DOI
- 10.21203/rs.3.rs-1653069/v1
